ORIGINAL ARTICLE
SELF-ASSESSMENT OF HEARING USING A MOBILE APP AMONG COVID-19 PATIENTS
Katarzyna Resler 1, A-B,D-F
,
 
Marcin Masalski 1,2, A-E
,
 
Mateusz Babicki 3, A-B,E
,
 
Marcin Fraczek 1, A,C-F
 
 
 
More details
Hide details
1
Department and Clinic of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, Poland
 
2
Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Poland
 
3
Department of Family Medicine, Wroclaw Medical University, Poland
 
 
A - Research concept and design; B - Collection and/or assembly of data; C - Data analysis and interpretation; D - Writing the article; E - Critical revision of the article; F - Final approval of article;
 
 
Submission date: 2022-05-28
 
 
Final revision date: 2022-11-15
 
 
Acceptance date: 2022-12-13
 
 
Online publication date: 2022-12-29
 
 
Publication date: 2022-12-29
 
 
Corresponding author
Katarzyna Resler   

Department and Clinic of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, Borowska 213, 50-556, Wroclaw, Poland
 
 
J Hear Sci 2022;12(4):19-25
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The effect of SARS-CoV-2 on hearing has not been thoroughly examined. Factors limiting hearing tests in COVID-19 patients are hygiene requirements and the need to use specialized equipment. The objective of the study was to assess changes in hearing thresholds between diagnosis of COVID-19 and convalescence using a mobile app.

Material and methods:
Patients with mild to moderate COVID-19 symptoms, who were isolating at home were enrolled in the study between 1 September 2020 and 31 January 2021. Subjects answered an online medical survey and self-assessed hearing thresholds using the Hearing TestTM mobile app (e-audiologia.pl). These procedures were done twice, once at the time of diagnosis and again 2 weeks after convalescence.

Results:
A total of 67 subjects were found eligible for the study. At most frequencies the patients’ hearing did not differ between the first and second examinations; however, for 4 kHz, a statistically significant improvement in the hearing threshold was found (p = 0.05). Survey review revealed noticeable improvement (p = 0.001) over time in smell, taste, and nasal congestion.

Conclusions:
It seems that SARS-CoV-2 infection caused a transient and selective (at 4 kHz) hearing impairment in patients who had had mild to moderate infection. The results suggest that as olfactory function returns after COVID-19, an improvement in hearing can be expected. Solutions based on mobile technology are useful for monitoring the hearing of patients in a pandemic.

 
REFERENCES (43)
1.
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020; 579: 270–3.
 
2.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020; 382: 727–33.
 
3.
Gorbalenya AE, Baker SC, Baric RS, De Groot RJ, Drosten Ch, Gulayeva AA, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol, 2020; 5: 536–44.
 
4.
World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report: 1 January 2020. Available at https: //apps.who.int/iris/handle/10665/330760.
 
5.
Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol, 2020; 41: 1100–15.
 
6.
Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol, 2020; 109: 531–8.
 
7.
Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol, 2020; 19: 767–83.
 
8.
Mullol J, Alobid I, Mariño-Sánchez F, Izquierdo-Dominguez A, Marin C, Klimek L, et al. The loss of smell and taste in the COVID-19 outbreak: a tale of many countries. Curr Allergy Asthma Rep, 2020; 20: 61.
 
9.
Li Y, Bai W, Hashikawa T. The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients. J Med Virol, 2020; 92: 552–5.
 
10.
Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell, 2020; 183: 16–27.
 
11.
Cohen BE, Durstenfeld A, Roehm PC. Viral causes of hearing loss: a review for hearing health professionals. Trends Hear, 2014; 18: 233121651454136.
 
12.
Mustafa MWM. Audiological profile of asymptomatic COVID-19 PCR-positive cases. Am J Otolaryngol, 2020; 41: 102483.
 
13.
Kilic O, Kalcioglu MT, Cag Y, Tuysuz O, Pektas E, Caskurlu H, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARS-CoV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis, 2020; 97: 208–11.
 
14.
Karimi-Galougahi M, Naeini AS, Raad N, Mikaniki N, Ghorbani J. Vertigo and hearing loss during the COVID-19 pandemic: is there an association? Acta Otorhinolaryngol Ital, 2020; 40: 463–5.
 
15.
World Health Organization. Advice for the public: Coronavirus disease (COVID-19). Available from: https: //www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public [Accessed 28.11.2022].
 
16.
Latifi R, Doarn CR. Perspective on COVID-19: finally, telemedicine at center stage. Telemed e-Health, 2020; 26: 1106–9.
 
17.
Iyengar K, Upadhyaya GK, Vaishya R, Jain V. COVID-19 and applications of smartphone technology in the current pandemic. Diabetes Metab Syndr Clin Res Rev, 2020; 14: 733–7.
 
18.
Thai-Van H, Bakhos D, Bouccara D, Loundon N, Marx M, Mom T, et al. Telemedicine in Audiology. Best practice recommendations from the French Society of Audiology (SFA) and the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL). Eur Ann Otorhinolaryngol Head Neck Dis, 2021; 138(5): 363–75.
 
19.
Masalski M, Grysiński T, Kręcicki T. Hearing tests based on biologically calibrated mobile devices: comparison with pure-tone audiometry. JMIR mHealth uHealth, 2018; 6: e10.
 
20.
Masalski M, Morawski K. Worldwide prevalence of hearing loss among smartphone users: cross-sectional study using a mobile-based app. J Med Internet Res, 2020; 22: e17238.
 
21.
Sahin AR. 2019 novel Coronavirus (COVID-19) outbreak: a review of the current literature. Eurasian J Med Oncol, 2020; 4(1): 1–7.
 
22.
De Luca P, Cassandro E, Scarpa A, Cassandro C, Ralli M, Gioacchini FM, et al. Sudden sensorineural hearing loss and COVID-19. Int J Infect Dis, 2020; 101: 201–2.
 
23.
Munro KJ, Uus K, Almufarrij I, Chaudhuri N, Yioe V. Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases. Int J Audiol, 2020; 59: 889–90.
 
24.
Jacob J, Flannery W, Mostert C. Novel ENT triad of anosmia, ageusia and hearing impairment in COVID‐19. Intern Med J, 2020; 50: 1155.
 
25.
Degen C, Lenarz T, Willenborg K. Acute profound sensorineural hearing loss after COVID-19 pneumonia. Mayo Clin Proc, 2020; 95: 1801–3.
 
26.
Sun R, Liu H, Wang X. Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean J Radiol, 2020; 21: 541.
 
27.
Lang B, Hintze J, Conlon B. Coronavirus disease 2019 and sudden sensorineural hearing loss. J Laryngol Otol, 2020; 134: 1026–8.
 
28.
Oliveira CA, Sampaio AL, Bahmad, Jr. FM, Araújo MFS. Viral etiology for inner ear diseases: proven, unproven, unlikely. ORL, 2008; 70: 42–51.
 
29.
Dror AA, Kassis-Karayanni N, Oved A, Daoud A, Eisenbach N, Mizrachi M, et al. Auditory performance in recovered SARS-CoV-2 patients. Otol Neurotol, 2020; 42: 666–670.
 
30.
Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID-19. BMJ Case Rep, 2020; 13: e238419.
 
31.
Song P, Li W, Xie J, Hou Y, You C. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta, 2020; 509: 280–7.
 
32.
Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: the anger of inflammation. Cytokine, 2020; 133: 155151.
 
33.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol, 2020; 77: 683.
 
34.
Yoshimura H, Takumi Y, Nishio S, Suzuki N, Iwasa Y, Usami S. Deafness gene expression patterns in the mouse cochlea found by microarray analysis. PLoS One, 2014; 9: e92547.
 
35.
Guipponi M, Toh M-Y, Tan J, Park D, Hanson K, Ballana E, et al. An integrated genetic and functional analysis of the role of type II transmembrane serine proteases (TMPRSSs) in hearing loss. Hum Mutat, 2008; 29: 130–41.
 
36.
Uranaka T, Kashio A, Ueha R, Sato T, Bing H, Ying G, et al. Expression of ACE2, TMPRSS2, and furin in mouse ear tissue, and the implications for SARS‐CoV‐2 infection. Laryngoscope, 2021; 131(6): E2013–E2017.
 
37.
Stefano GB, Ptacek R, Ptackova H, Martin A, Kream RM. Selective neuronal mitochondrial targeting in SARS-CoV-2 infection affects cognitive processes to induce ‘brain fog’ and results in behavioral changes that favor viral survival. Med Sci Monit, 2021; 27: e930886.
 
38.
Kim J-E, Heo J-H, Kim H, Song SH, Park SS, Park TH, et al. Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol, 2017; 13: 227.
 
39.
Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and ageusia: common findings in COVID‐19 patients. Laryngoscope, 2020; 130: 1787.
 
40.
Lechien JR, Chiesa‐Estomba CM, Place S, Van Laethem Y, Cabaraux P, Mat Q, et al. Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019. J Intern Med, 2020; 288: 335–44.
 
41.
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngology, 2020; 277: 2251–61.
 
42.
Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med, 2020; 35: 1545–9.
 
43.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020; 395: 507–13.
 
Journals System - logo
Scroll to top